ESC Premium Access

Heart failure and diabetes: a treacherous combination

Event: ESC CONGRESS 2017
Topic: Heart failure, other
Session type: Advances in Science
Date: 29 August 2017
Time: 08:30 - 10:00

Session

5 presentations in this session

State of the Art: glucose-lowering drugs and cardiovascular outcomes

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

Heart failure with mid range ejection fraction, characteristics and prognosis in patients with and without type 2 diabetes

Speaker: Doctor I. Johansson (Stockholm, SE)
Thumbnail

How does diabetes affect iron status in patients with heart failure?

Speaker: Doctor M. Drozd (Wroclaw, PL)
Thumbnail

Empagliflozin reduces mortality in analyses adjusted for control of blood pressure, low density lipoprotein cholesterol and HbA1c over time

Speaker: Doctor D. Fitchett (Toronto, CA)
Thumbnail

Heart failure and diabetes: lessons from the ESC long-term registry

Speaker: Professor O. Chioncel (Bucharest, RO)
Thumbnail

5 speakers from this session

Professor Stefan Anker

Charite Campus Virchow Clinic, Berlin (Germany)
106 presentations
2 followers

Doctor Isabelle Johansson

Karolinska Institute, Stockholm (Sweden)
1 presentation
0 follower

Doctor Marcin Drozd

Wroclaw Medical University, Wroclaw (Poland)
1 presentation
0 follower

Doctor David Fitchett

St. Michael's Hospital, Toronto (Canada)
16 presentations
0 follower

Professor Ovidiu Chioncel

Institute of Cardiovascular Diseases "Prof. Dr. CC Iliescu", Bucharest (Romania)
16 presentations
2 followers

This platform is supported by

logo Novo Nordisk